FDA Releases Statement On BPA Report

WASHINGTON—The FDA released a statement regarding a subcommittee’s report on Bisphenol A (BPA) requesting the subcommittee provide additional insight on the topic

The subcommittee report to the Science Board raises important questions regarding the draft safety assessment, and the FDA looks forward to the review of the subcommittee's report by the Science Board on Oct 31.

The FDA agrees that, due to the uncertainties raised in some studies relating to the potential effects of low dose exposure to bisphenol A, additional research would be valuable. The FDA is already moving forward with planned research to address the potential low dose effects of bisphenol A, and will carefully evaluate the findings of these studies.

To view a copy of the Subcommittee Report, click here